Navigation auf uzh.ch
Navigation auf uzh.ch
| screen # | screen description |
| GS007 (XLSX, 22 KB) | Clear Strategy screen I &II, pH 5.5 & 6.5; (MDL:MD1-14 & MD1-15) |
| GS008 (XLSX, 22 KB) | Clear Strategy screen I ⅈ pH 7.5 & 8.5; (MDL:MD1-14 & MD1-15) |
| GS020 (XLSX, 20 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4,NaCl 1.0M + 150mM (Membrane Protein - MacKinnon Screen) |
| GS021 (XLSX, 20 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4, (NH4)2SO4 200 mM; Mg-Acetate 50 mM, (Membrane Protein - MacKinnon Screen) |
| GS022 (XLSX, 21 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4,K-phosphate // Li-Na-sulfate (Membrane Protein - MacKinnon Screen) |
| GS023 (XLSX, 20 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4,KCl 500mM // CaCl2 200mM (Membrane Protein - MacKinnon Screen) |
| GS024 (XLSX, 20 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4, Ammonium-Formate; Zinc Acetate, Potassium Iodide (Membrane Protein - MacKinnon Screen) |
| GS025 (XLSX, 20 KB) | PEG400 15-45%//PEG4000 5-30%, pH gradient 4.5 ~ 9.4,No Addition; Potassium-Sodium-Tartrate (Membrane Protein - MacKinnon Screen) |
| GS027 (XLSX, 19 KB) | JCSG-plus™ MD1-37 |
| GS028 (XLSX, 17 KB) | PACT premier™ MD1-29, PACT Buffer Protocols (PDF, 594 KB) |
| GS031 (XLSX, 19 KB) | Structure Screen I & II, (MDL: MD1-01 & MD1-02) |
| GS032 (XLSX, 21 KB) | MemStart & MemSys, (MDL: MD1-21 & MD1-25) |
| GS036 (XLSX, 23 KB) | The Anions Suite (Qiagen:Art#130707) |
| GS037 (XLSX, 22 KB) | The Cation Suite (Qiagen:Art#130708) |
| GS044 (XLSX, 19 KB) | Additive screen: JBScreen Plus (Jenabioscience:CS-507L) customer provide buffer solution~10% more concentrated |
| GS045 (XLSX, 23 KB) | Mem Gold (MDL: MD1-41) |
| GS046 (XLSX, 21 KB) | Peg/Ion screen (Hampton Research: HR2-126 & HR2-098) |
| GS048 (XLSX, 22 KB) | Crystal Screen & Crystal Screen 2: (Hampton research:HR2-110 & HR2-112) |
| GS055 (XLSX, 763 KB) | MIDAS, (MDL:MD1-106), Crystallization conditions with alternative polymeric precipitant, MDL Datasheet (PDF, 244 KB) |
| GS056 (XLSX, 24 KB) | HELIX, (MDL:MD1-68), Crystallization conditions for nucleic acid fragments, double stranded DNA, RNA and ribozymes, MDL Datasheet (PDF, 244 KB) |
| GS072 (XLSX, 21 KB) | MemMeso™- optimized screen for LCP crystallization, Molecular Dimensions MD1-85 |
| GS073 (XLSX, 25 KB) | Index HT; Hampton Research HR2-144 |
| GS074 (XLSX, 21 KB) | SG1 (ShotGun Screen), Molecular Dimensions MD1-88 (PDF, 176 KB), set of conditions that occur with highest, non redundant frequency amongst all PDB deposit. A drunken search in crystallization space, Vincent J. Fazio,a Thomas S. Peata and Janet Newman |
| GS075 (XLSX, 19 KB) | Morpheus, Molecular Dimensions, MD1-46; Datasheet-GS075 (PDF, 676 KB) |
| GS076 (XLSX, 19 KB) | Pi-PEG, Jena Bioscience, CS-128 |
| GS078 (XLSX, 20 KB) | Additiv Screen; Hampton Research, HR2-138 |
| GS079 (XLSX, 19 KB) | Gras 1;Hampton Research; HR2-451; different short PEG in low concentration with different salt, pH: 4-9 |
| GS080 (XLSX, 19 KB) | Gras 3; Hampton Research, HR2-453; different short PEG in low concentration with different salt, pH: 4-9 |
| GS081 (XLSX, 20 KB) | Gras 5; Hampton Research, HR2-455; different short PEG in low concentration with different salt, pH: 4-9 |
| GS083 (XLSX, 24 KB) | BCS Screen, Molecular Dimensions, MD1-104 |
| GS084 (XLSX, 24 KB) | Crystal Screen 1+2 Cryo, Hampton Research; HR2-122 + HR2-121 |
| GS085 (XLSX, 24 KB) | (NH4)2SO4 0.5-3.0M, pH-gradient:3~10 |
| GS086 (XLSX, 18 KB) | Small Molecule Anion screen (PDF, 665 KB) is a crystallisation screen for organic salts, active pharmaceutical ingredients, coordination complexes and peptides. Molecular Dimensions MD1-125 |
| GS087 (XLSX, 26 KB) | Morpheus Fusion (PDF, 3 MB) is a incomplete factorial protein crystallization screen for membrane and soluble proteins. Molecular Dimensions MD1-129 |
